Pembrolizumab shown to be “better” than standard chemotherapy in lung cancer

But honestly, median survival of 5 months which was significant by the way. Is this realistically significant though, adding the financial burden to it?

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s